Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
Cancer Statistics, 2010
2010 • 12,557 citations
Permutation tests for joinpoint regression with applications to cancer rates
2000 • 4,530 citations
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 • 2,702 citations
Campbell-Walsh urology
2012 • 2,651 citations
Kim H‐J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351
2001 • 899 citations
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 • 704 citations
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
1999 • 697 citations
A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy
2008 • 535 citations
Efficient interval estimation for age-adjusted cancer rates
2006 • 511 citations
Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis
1995 • 338 citations
Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome
2003 • 323 citations
Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas
2006 • 315 citations
Occupation and cancer of the lower urinary tract
1972 • 272 citations
FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma
2004 • 215 citations
A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
2009 • 171 citations
Smoking and Cancer of the Lower Urinary Tract
1971 • 159 citations
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
2002 • 143 citations
Management of Low Grade Papillary Bladder Tumors
2007 • 136 citations
Associations between Bladder Cancer Risk Factors and Tumor Stage and Grade at Diagnosis
1994 • 116 citations
Evaluation and follow-up strategies for superficial bladder cancer
2003 • 116 citations
Ethnic Differences in Bladder Cancer Survival
2011 • 108 citations
Urothelial Tumors of the Bladder
2012 • 90 citations
Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
2001 • 89 citations
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens
2004 • 85 citations
Time trend and age-period-cohort effect on incidence of bladder cancer in Connecticut, 1935–1992
1996 • 84 citations
Genetic Susceptibility to Distinct Bladder Cancer Subphenotypes
2009 • 74 citations
Cigarette smoking and subtypes of bladder cancer
2011 • 69 citations
Surveillance of urothelial carcinoma
2009 • 68 citations
Comparing Standardized Rates of Events
1994 • 61 citations
Marital status and stage at diagnosis of cutaneous melanoma
2010 • 53 citations
Are the known bladder cancer risk-factors associated with more advanced bladder cancer?
1993 • 41 citations
Allelic deletions of cell growth regulators during progression of bladder cancer.
2000 • 30 citations
Cited By (0)
No citing papers found in database